Pre-Approval Patient Access Webinar

RUF will be participating in an upcoming webinar hosted by Johnson & Johnson and NYU School of Medicine on June 13th, 2017 from 12:00pm-1:00pm.

Click here to register by May 23d

The agenda is available here

Agenda highlights The pre-approval access landscape is constantly evolving and remains a hot topic. Hear the latest on Right to Try legislation and the implications of the passage of the 21st Century Cures Act.  Also learn more about the expansion of the Compassionate Use Advisory Committee (CompAC) and the development of Reagan-Udall’s Expanded Access Navigator, two great examples of recent progress made for patients.

Join us for an interactive discussion led by:

Amrit Ray, MD, MBA Chief Medical Officer Janssen Pharmaceuticals, Johnson & Johnson

Arthur Caplan, PhD Director, Division of Medical Ethics NYU School of Medicine Drs. William F. and Virginia Connolly Mitty Professor of Bioethics

June Wasser, MA Executive Director Reagan-Udall Foundation for the FDA

David Dorsey Senior Director, Americas Head, Global Regulatory Policy and Intelligence Janssen Pharmaceuticals, Johnson & Johnson